ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 67 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $33,000 | -36.5% | 23,093 | 0.0% | 0.00% | – |
| Q4 2017 | $52,000 | -34.2% | 23,093 | 0.0% | 0.00% | – |
| Q3 2017 | $79,000 | 0.0% | 23,093 | +3.6% | 0.00% | – |
| Q2 2017 | $79,000 | +54.9% | 22,298 | +49.6% | 0.00% | – |
| Q1 2017 | $51,000 | -21.5% | 14,908 | +6.1% | 0.00% | – |
| Q4 2016 | $65,000 | +25.0% | 14,050 | +14.6% | 0.00% | – |
| Q3 2016 | $52,000 | +85.7% | 12,264 | +5.1% | 0.00% | – |
| Q2 2016 | $28,000 | -34.9% | 11,664 | +4.2% | 0.00% | – |
| Q3 2015 | $43,000 | – | 11,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |